Author:
Grab Sheila,Rohan Lisa C.
Funder
National Institute of Allergy and Infectious Diseases
Bill & Melinda Gates Foundation
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science
Reference31 articles.
1. Bala R, Pawar P, Khanna S, Arora S. Orally dissolving strips: a new approach to oral drug delivery system. Int J Pharm Investig. 2013;3(2):67–76.
https://doi.org/10.4103/2230-973X.114897
.
2. Ferguson LM, Rohan LC. The importance of the vaginal delivery route for antiretrovirals in HIV prevention. Ther Deliv. 2011;2(12):1535–50.
https://doi.org/10.4155/tde.11.126
.
3. Bunge KE, Dezzutti CS, Rohan LC, Hendrix CW, Marzinke MA, Richardson-Harman N, et al. A phase 1 trial to assess the safety, acceptability, pharmacokinetics, and pharmacodynamics of a novel dapivirine vaginal film. JAIDS J Acquir Immune Defic Syndr. 2016;71(5):498–505.
4. Robinson JA, Marzinke MA, Bakshi RP, Fuchs EJ, Radebaugh CL, Aung W, et al. Comparison of dapivirine vaginal gel and film formulation pharmacokinetics and pharmacodynamics (FAME 02B). AIDS Res Hum Retrovir. 2017;33(4):339–46.
https://doi.org/10.1089/AID.2016.0040
.
5. Bunge K, Dezzutti C, Macio I, Hendrix C, Lisa C, Rohan L, editors. FAME-02: a phase I trial to assess safety, PK, and PD of gel and film formulations of dapivirine. Conference on Retroviruses and Opportunistic Infections (CROI); 2014.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献